• For Individuals
  • For Institutions
  • Download
  • Help

  • About

longbridgelongbridge
longbridgelongbridge
Why Longbridge?
Investment Products
Trading Tools
Trading Platform
Developers
Market Data Services
Analysis Tools
News Services
Dolphin Research
Pricing
Markets
Global Markets
Stock Screener
Information
Research
News
Live
Community
Academy
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文（廣東話）Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
Posts
News
Financials

Event Tracking

Nov6
ImmunityBio released FY2025 9 Months earnings on November 5 (EST), actual revenue USD 75M, actual EPS USD -0.3272
04:00
ImmunityBio released FY2025 Q3 earnings on November 5, 2025 (EST), actual revenue USD 32.06 M (forecast USD 31.88 M), actual EPS USD -0.071 (forecast USD -0.108)
04:00
Nov5
ImmunityBio Reports Sales Growth and Launches Glioblastoma Clinical Trial
03:16
Aug26
Immunitybio's Therapy Achieves 100% Disease Control Rate in Glioblastoma Patients
12:42
Aug19
ImmunityBio Launches Phase 2 Clinical Study for ANKTIVA® in Long COVID Symptoms
12:31
Aug13
ImmunityBio Reports Early Positive Results for CD19 CAR-NK Therapy in Relapsed or Refractory Non-Hodgkin Lymphoma Patients
12:31

Schedules & Filings

Schedules
Filings
Nov5
Earning Release(EST)

FY2025 Q3 Earning Release (USD) Revenue 32.06 M, Net Income -67.25 M, EPS -0.071

Aug5
Earning Release(EST)

FY2025 Q2 Earning Release (USD) Revenue 26.43 M, Net Income -92.56 M, EPS -0.1042

May12
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 16.52 M, Net Income -129.65 M, EPS -0.1519

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FOXX
3.780
+87.03%
+1.759
MFI
15.300
+38.34%
+4.240
NVVE
0.2261
+37.78%
+0.062
IVDA
0.8928
+37.25%
+0.243
EPSM
4.880
+33.33%
+1.220
BEAGR
0.3990
+32.56%
+0.098
NVRI
17.473
+28.76%
+3.903
MNDR
3.891
+27.99%
+0.845
AIIO
0.9878
+26.64%
+0.208
IVP
0.1557
+25.56%
+0.031
View More
Terms & Conditions
  • Terms of Service
  • Privacy Policy